var title_f14_4_14400="Gram stain sputum 12";
var content_f14_4_14400=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F77431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F77431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gram stain sputum 12",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14400=[""].join("\n");
var outline_f14_4_14400=null;
var title_f14_4_14401="Erythema elevatum diutinum - lower extremities";
var content_f14_4_14401=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57008&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57008&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema elevatum diutinum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nodular lesions are present on the knees in this patient with erythema elevatum diutinum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14401=[""].join("\n");
var outline_f14_4_14401=null;
var title_f14_4_14402="Patient information: Acute myeloid leukemia (AML) (The Basics)";
var content_f14_4_14402=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"15\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?2/47/2802\">",
"         Patient information: Bone marrow transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/13/38098\">",
"         Patient information: Leukemia in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/40/24194\">",
"         Patient information: Leukemia in children (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?33/30/34275\">",
"         Patient information: Acute myeloid leukemia (AML) treatment in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/4/34886\">",
"         Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Acute myeloid leukemia (AML) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/acute-myeloid-leukemia-aml-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H13396663\">",
"      <span class=\"h1\">",
"       What is acute myeloid leukemia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Acute myeloid leukemia, called &ldquo;AML,&rdquo; is a type of blood cancer. AML is usually fast-growing and needs to be treated quickly.",
"     </p>",
"     <p>",
"      Blood is made up of different types of cells. These cells are made in the middle of your bones, in a part called the bone marrow. When people have AML, their bone marrow makes abnormal blood cells instead of normal blood cells. These abnormal blood cells grow out of control, get into the blood, and travel around the body. Sometimes, these cells collect in certain parts of the body.",
"     </p>",
"     <p>",
"      When the bone marrow makes abnormal blood cells, it does not make the normal blood cells a person&rsquo;s body needs. This can cause symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13396670\">",
"      <span class=\"h1\">",
"       What are the symptoms of AML?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common symptoms of AML include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feeling very tired and weak",
"       </li>",
"       <li>",
"        Bleeding more easily than normal",
"       </li>",
"       <li>",
"        Getting sick from infections more easily than normal",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13396677\">",
"      <span class=\"h1\">",
"       Is there a test for AML?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse will talk with you and do an exam. He or she will also do:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Bone marrow biopsy &ndash; A doctor will take a very small sample of the bone marrow. Then another doctor will look at the cells under a microscope to see if abnormal (cancer) cells are present.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      There are different types of AML. The test results can show which type you have. The right treatment for you will depend a lot on your age and the type of AML you have.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13396684\">",
"      <span class=\"h1\">",
"       How is AML treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment for AML usually includes 2 parts.",
"     </p>",
"     <p>",
"      The first part of treatment is called &ldquo;induction of remission&rdquo; and lasts about 4 weeks. During this part, people stay in the hospital and get",
"      <strong>",
"       chemotherapy",
"      </strong>",
"      . Chemotherapy is the term doctors use to describe a group of medicines that kill cancer cells.",
"     </p>",
"     <p>",
"      Many people are in &ldquo;remission&rdquo; after the chemotherapy. This means that doctors do not see any abnormal blood cells in the blood or bone marrow. But even though doctors do not see any abnormal cells, there are still abnormal cells in the body. To kill these cells and prevent the AML from returning, people need more treatment.",
"     </p>",
"     <p>",
"      The second part of treatment is called &ldquo;post-remission therapy.&rdquo; During this time, people can have one or more of the following treatments:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        More chemotherapy &ndash; People stay in the hospital for a few days each month to get chemotherapy. This treatment can last 3 or 4 months.",
"       </li>",
"       <li>",
"        Radiation therapy &ndash; Radiation kills cancer cells.",
"       </li>",
"       <li>",
"        Bone marrow transplant &ndash; This treatment replaces cells in the bone marrow that are killed by chemotherapy or radiation. These &ldquo;donor&rdquo; cells can come from different places, including:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        People who are related to you, and whose blood matches yours",
"       </li>",
"       <li>",
"        People who are not related to you, but whose blood matches yours",
"       </li>",
"       <li>",
"        Blood (that matches yours) from a newborn baby&rsquo;s umbilical cord",
"       </li>",
"       <li>",
"        You &ndash; Your cells can be taken out of your bone marrow before your treatment is completed and put back in after you have completed chemotherapy or radiation treatment.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13396691\">",
"      <span class=\"h1\">",
"       What happens after treatment?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After treatment, your doctor will check you every so often to see if the cancer comes back. Regular follow-ups include talking with your doctor, exams, and blood tests. Sometimes, your doctor will also do a bone marrow biopsy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13396698\">",
"      <span class=\"h1\">",
"       What happens if the AML comes back?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If the AML comes back, you might have more chemotherapy, radiation, or bone marrow transplantation.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13396705\">",
"      <span class=\"h1\">",
"       What else should I do?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It&rsquo;s important to follow all your doctor&rsquo;s instructions about visits and tests. It&rsquo;s also important to talk to your doctor about any side effects or problems you have during treatment.",
"     </p>",
"     <p>",
"      Getting treated for AML involves making many choices, such as what treatment to have.",
"     </p>",
"     <p>",
"      Always let your doctors and nurses know how you feel about a treatment. Any time you are offered a treatment, ask:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        What are the benefits of this treatment? Is it likely to help me live longer? Will it reduce or prevent symptoms?",
"       </li>",
"       <li>",
"        What are the downsides to this treatment?",
"       </li>",
"       <li>",
"        Are there other options besides this treatment?",
"       </li>",
"       <li>",
"        What happens if I do not have this treatment?",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13396712\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/13/38098?source=see_link\">",
"       Patient information: Leukemia in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/40/24194?source=see_link\">",
"       Patient information: Leukemia in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/47/2802?source=see_link\">",
"       Patient information: Bone marrow transplant (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?33/30/34275?source=see_link\">",
"       Patient information: Acute myeloid leukemia (AML) treatment in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/4/34886?source=see_link\">",
"       Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?14/4/14402?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15790 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-E2FE460E4C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14402=[""].join("\n");
var outline_f14_4_14402=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13396663\">",
"      What is acute myeloid leukemia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13396670\">",
"      What are the symptoms of AML?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13396677\">",
"      Is there a test for AML?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13396684\">",
"      How is AML treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13396691\">",
"      What happens after treatment?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13396698\">",
"      What happens if the AML comes back?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13396705\">",
"      What else should I do?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13396712\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/30/34275?source=related_link\">",
"      Patient information: Acute myeloid leukemia (AML) treatment in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/47/2802?source=related_link\">",
"      Patient information: Bone marrow transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/4/34886?source=related_link\">",
"      Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/13/38098?source=related_link\">",
"      Patient information: Leukemia in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/40/24194?source=related_link\">",
"      Patient information: Leukemia in children (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_4_14403="Prostate CA perineural invasion";
var content_f14_4_14403=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F69000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F69000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prostate cancer with perineural invasion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 375px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph of an hematoxylin and eosin stained section of a prostate core needle biopsy. One of the diagnostic features of prostate adenocarcinoma is perineural invasion (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ximing Yang, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14403=[""].join("\n");
var outline_f14_4_14403=null;
var title_f14_4_14404="Propantheline: Drug information";
var content_f14_4_14404=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Propantheline: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?6/27/6580?source=see_link\">",
"    see \"Propantheline: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/37/27219?source=see_link\">",
"    see \"Propantheline: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F214437\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anticholinergic Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F214415\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Antisecretory (unlabeled use), antispasmodic:",
"     </b>",
"     Oral: 15 mg 3 times/day before meals or food and 30 mg at bedtime",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F214427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/37/27219?source=see_link\">",
"      see \"Propantheline: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Antisecretory (unlabeled use):",
"     </b>",
"     Oral: 1-2 mg/kg/day in 3-4 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Antispasmodic:",
"     </b>",
"     Oral: 2-3 mg/kg/day in divided doses every 4-6 hours and at bedtime",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F214416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antisecretory (unlabeled use): 7.5 mg 3 times/day before meals and at bedtime; increase as necessary to a maximum of 30 mg 3 times/day",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F214400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as bromide: 15 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F214386\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F11563787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer 30 minutes before meals and at bedtime.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F214401\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunctive treatment of peptic ulcer",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F12810272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Decreased salivation and drooling",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9959527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F214435\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Palpitation, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Confusion, dizziness, drowsiness, headache, insomnia, nervousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Suppression of lactation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Bloated feeling, constipation,  loss of taste, nausea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Impotence, urinary hesitancy, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, cycloplegia, mydriasis, ocular tension increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, anaphylaxis, diaphoresis decreased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F214404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Severe ulcerative colitis, toxic megacolon, obstructive disease of the GI or urinary tract; glaucoma; myasthenia gravis; unstable cardiovascular adjustment in acute hemorrhage; intestinal atony of elderly or debilitated patients",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F214390\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: May cause drowsiness and/or blurred vision, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diarrhea: May be a sign of incomplete intestinal obstruction, treatment should be discontinued if this occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Heat prostration: May occur in the presence of increased environmental temperature; use caution in hot weather and/or exercise.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with coronary artery disease, tachyarrhythmias, heart failure, or hypertension; evaluate tachycardia prior to administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Endocrine disease: Use with caution in patients with endocrine diseases.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal infections: Use with caution in patients with GI infections.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hiatal hernia: Use with caution in patients with hiatal hernia with reflux esophagitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperthyroidism: Use with caution in patients with hyperthyroidism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuropathy: Use with caution in patients with autonomic neuropathy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use in this age group due to potent anticholinergic adverse effects and uncertain effectiveness (Beers Criteria).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F214395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AbobotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of AbobotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: Anticholinergic Agents may enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirabegron: Anticholinergic Agents may enhance the therapeutic effect of Mirabegron. This may result in acute urinary retention.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Chloride: Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Chloride.  Management: Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RimabotulinumtoxinB: Anticholinergic Agents may enhance the anticholinergic effect of RimabotulinumtoxinB.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Secretin: Anticholinergic Agents may diminish the therapeutic effect of Secretin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Anticholinergic Agents may enhance the adverse/toxic effect of Topiramate. Specifically, the risk of oligohidrosis and hyperthermia may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F214396\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14079705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F214417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F214406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken 30 minutes before meals so that the drug's peak effect occurs at the proper time. The tablet (15 mg) contains lactose 23.2 mg.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F2524698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Propantheline Bromide Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (100): $73.11",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ercoril (DK);",
"     </li>",
"     <li>",
"      Ercotina (SE);",
"     </li>",
"     <li>",
"      Pro-Banthine (AU, BB, BE, BF, BJ, BM, BS, BZ, CI, CY, ET, FR, GB, GH, GM, GN, GY, HK, ID, IE, IN, JM, KE, LR, LU, MA, ML, MR, MU, MW, NE, NG, NL, SC, SD, SL, SN, SR, TN, TT, TW, TZ, UG, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Propanline (TW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F214389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competitively blocks the action of acetylcholine at postganglionic parasympathetic receptor sites",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F214403\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 30-45 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination, serum: Average: 1.6 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14404/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9823 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-201.211.0.116-2901CD32CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14404=[""].join("\n");
var outline_f14_4_14404=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214437\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214415\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214427\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214416\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214400\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214386\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11563787\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214401\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12810272\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9959527\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214435\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214404\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214390\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299949\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214395\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214396\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14079705\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214417\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214406\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2524698\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038784\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214389\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214403\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9823\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9823|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?6/27/6580?source=related_link\">",
"      Propantheline: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/37/27219?source=related_link\">",
"      Propantheline: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_4_14405="Ceftazidime: Pediatric drug information";
var content_f14_4_14405=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ceftazidime: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"    see \"Ceftazidime: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?34/6/34915?source=see_link\">",
"    see \"Ceftazidime: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F147933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fortaz&reg;;",
"     </li>",
"     <li>",
"      Tazicef&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F147934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ceftazidime For Injection;",
"     </li>",
"     <li>",
"      Fortaz&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1046099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Cephalosporin (Third Generation)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     AAP recommendations (",
"     <i>",
"      Red Book",
"     </i>",
"     , 2009):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PNA 0-28 days and &lt;1200 g: 50 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PNA &lt;7 days:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     1200-2000 g: 50 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;2000 g: 50  mg/kg/dose every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PNA &ge;7 days and &ge;1200 g: 50 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Manufacturer&rsquo;s recommendation: 30 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Alternative dosing:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GA &le;32 weeks: 50 mg/kg/dose every 12 hours; some reports use 25 mg/kg/dose every 24 hours with adequate serum concentrations in premature neonates (van den Anker, 1995a; van den Anker, 1995)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GA &gt;32 weeks:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     PNA &lt;7 days: 50 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     PNA &ge;7 days: 50 mg/kg/dose every 8 hours",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1046092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"      see \"Ceftazidime: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants and Children 1 month to 12 years: 100-150 mg/kg/day divided every 8 hours; maximum dose: 6 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Meningitis: 150 mg/kg/day divided every 8 hours; maximum dose: 6 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults: 1-2 g every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Urinary tract infections: 250-500 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing interval in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-50 mL/minute: Administer every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-30 mL/minute: Administer every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: Administer every 24-48 hours",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F147911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed iso-osmotic solution, as sodium [strength expressed as base]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fortaz&reg;: 1 g (50 mL); 2 g (50 mL) [contains sodium ~54 mg (2.3 mEq)/g]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 1 g, 2 g, 6 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fortaz&reg;: 500 mg, 1 g, 2 g, 6 g [contains sodium ~54 mg (2.3 mEq)/g]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tazicef&reg;: 1 g, 2 g, 6 g [contains sodium ~54 mg (2.3 mEq)/g]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F147895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Injection",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1046102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Any carbon dioxide bubbles that may be present in the withdrawn solution should be expelled prior to injection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     IVP: Administer over 3-5 minutes at a maximum concentration of 180 mg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V. intermittent infusion: Administer over 15-30 minutes at a final concentration &le;40 mg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.: Deep I.M. injection into a large muscle mass such as the upper outer quadrant of the gluteus maximus or lateral part of the thigh. May dilute vial using SWI or 0.5% or 1% lidocaine to a final concentration of 280 mg/mL (see package insert)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F147985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR, NS, Ringer's injection, sterile water for injection, in peritoneal dialysis solutions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, allopurinol, amifostine, amikacin, anidulafungin, aztreonam, bivalirudin, ciprofloxacin, daptomycin, dexmedetomidine, diltiazem, docetaxel, dopamine, enalaprilat, epinephrine, esmolol, etoposide phosphate, famotidine, fenoldopam, filgrastim, fludarabine, foscarnet, furosemide, gallium nitrate, gemcitabine, gentamicin, granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), hydromorphone, insulin (regular), ketamine, labetalol, linezolid, melphalan, meperidine, methylprednisolone sodium succinate, milrinone, morphine, ondansetron, paclitaxel, ranitidine, remifentanil, sufentanil, tacrolimus, telavancin, teniposide, thiotepa, tigecycline, tobramycin, valproate sodium, vinorelbine, zidovudine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Acetylcysteine, amiodarone, amphotericin B cholesteryl sulfate complex, amsacrine, azithromycin, caspofungin, dobutamine, doxorubicin liposome, erythromycin lactobionate, idarubicin, midazolam, pantoprazole, pemetrexed, pentamidine, phenytoin, warfarin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Aminopylline, cisatracurium, doxapram, drotrecogin alfa, fluconazole, nicardipine, propofol, sargramostim, theophylline, vancomycin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Dimenhydrinate, hydromorphone.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Pantoprazole.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1046096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reconstituted solution is stable for 24 hours at room temperature and 10 days when refrigerated; incompatible with sodium bicarbonate; potentially incompatible with aminoglycosides",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1046101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of infections of the respiratory tract, urinary tract, skin and skin structure, intra-abdominal, osteomyelitis, sepsis, and meningitis caused by susceptible gram-negative aerobic organisms such as Enterobacteriaceae and",
"     <i>",
"      Pseudomonas",
"     </i>",
"     ; pseudomonal infection in patient at risk of developing aminoglycoside-induced nephrotoxicity and/or ototoxicity; empiric therapy for febrile, granulocytopenic patients",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F147987\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       CefTAZidime may be confused with ceFAZolin, cefepime, cefoTEtan, cefOXitin,  cefTRIAXone",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Ceptaz&reg; may be confused with Septra&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Tazicef&reg; may be confused with Tazidime&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Ceftim [Portugual] and Ceftime [Thailand] brand names for ceftazidime may be confused with Ceftin brand name for cefuroxime [U.S., Canada]; Cefiton brand name for cefixime [Portugal]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F147984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Pain at injection site",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity reactions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Anaphylaxis, angioedema, asterixis, BUN increased, candidiasis, creatinine increased, dizziness, encephalopathy, eosinophilia, erythema multiforme, fever, headache, hemolytic anemia, hyperbilirubinemia, jaundice, leukopenia, myoclonus, nausea, neuromuscular excitability, paresthesia, phlebitis, pruritus, pseudomembranous colitis, rash, Stevens-Johnson syndrome, thrombocytosis, toxic epidermal necrolysis, transaminases increased, vaginitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Reactions reported with other cephalosporins: Agranulocytosis, aplastic anemia, cholestasis, colitis, hemolytic anemia, hemorrhage, interstitial nephritis, pancytopenia, prolonged PT, renal dysfunction, seizure, serum-sickness reactions, superinfection, toxic nephropathy, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1046105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ceftazidime, any component, or cephalosporins",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1046091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution and modify dosage in patients with impaired renal function; use with caution in patients with history of colitis or patients with penicillin hypersensitivity",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1046090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prolonged use may result in superinfection; do not use in patients with immediate-type hypersensitivity reactions to penicillin",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F147904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Cephalosporins (3rd Generation) may enhance the nephrotoxic effect of Aminoglycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Cephalosporins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Cephalosporins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F147907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5951787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies. Ceftazidime crosses the placenta and reaches the cord serum and amniotic fluid. An increase in most types of birth defects was not found following first trimester exposure to cephalosporins. Maternal peak serum concentration is unchanged in the first trimester. After the first trimester, serum concentrations decrease by approximately 50% of those in nonpregnant patients. Renal clearance is increased during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1046098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Renal function periodically when used in combination with aminoglycosides; with prolonged therapy also monitor hepatic and hematologic function periodically; number and type of stools/day for diarrhea",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1046089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bactericidal antibiotic with a mechanism similar to that of penicillins by binding to one or more of the penicillin-binding proteins; inhibits mucopeptide synthesis in the bacterial cell wall",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1046104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Widely distributed throughout the body including bone, bile, skin, CSF (diffuses into CSF at higher concentrations when the meninges are inflamed), endometrium, heart, pleural and lymphatic fluids; distributes into breast milk",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 17%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neonates &lt;23 days: 2.2-4.7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 1-2 hours (prolonged with renal impairment)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: I.M.: Within 60 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: By glomerular filtration with 80% to 90% of the dose excreted as unchanged drug in urine within 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Dialyzable (50% to 100%)",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1046106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sodium content of 1 g: 2.3 mEq",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Low DC, Bissenden JG, and Wise R, \"Ceftazidime in Neonatal Infections,\"",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 1985, 60(4):360-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14405/abstract-text/3890766/pubmed\" id=\"3890766\" target=\"_blank\">",
"        3890766",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McCracken GH Jr, Threlkeld N, and Thomas ML, &ldquo;Pharmacokinetics of Ceftazidime in Newborn Infants,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1984, 26(4):583-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14405/abstract-text/6393862/pubmed\" id=\"6393862\" target=\"_blank\">",
"        6393862",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      <i>",
"       Red Book: 2009 Report of the Committee on Infectious Diseases",
"      </i>",
"      , 28th ed, Pickering LK, ed, Elk Grove Village, IL: American Academy of Pediatrics, 2009.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Robinson DC, Cookson TL, and Grisafe JA, &ldquo;Concentration Guidelines for Parenteral Antibiotics in Fluid-Restricted Patients,&rdquo;",
"      <i>",
"       Drug Intell Clin Pharm",
"      </i>",
"      , 1987, 21(12):985-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14405/abstract-text/3428165/pubmed\" id=\"3428165\" target=\"_blank\">",
"        3428165",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tessin I, Trollfors B, Thiringer K, et al, \"Concentrations of Ceftazidime, Tobramycin and Ampicillin in the Cerebrospinal Fluid of Newborn Infants,\"",
"      <i>",
"       Eur J Pediatr",
"      </i>",
"      , 1989, 148(7):679-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14405/abstract-text/2663518/pubmed\" id=\"2663518\" target=\"_blank\">",
"        2663518",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van den Anker JN, Hop WC, Schoemaker RC, et al, \"Ceftazidime Pharmacokinetics in Preterm Infants: Effect of Postnatal Age and Postnatal Exposure to Indomethacin,\"",
"      <i>",
"       Br J Clin Pharmacol",
"      </i>",
"      , 1995, 40(5):439-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14405/abstract-text/8703647/pubmed\" id=\"8703647\" target=\"_blank\">",
"        8703647",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van den Anker JN, Schoemaker RC, van der Heijden BJ, et al, \"Once-Daily Versus Twice-Daily Administration of Ceftazidime in the Preterm Infant,\"",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1995, 39(9):2048-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14405/abstract-text/8540714/pubmed\" id=\"8540714\" target=\"_blank\">",
"        8540714",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13134 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-2522EA1FE6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14405=[""].join("\n");
var outline_f14_4_14405=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147933\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147934\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046099\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442226\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046092\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147911\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147895\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046102\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147985\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046096\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046101\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147987\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147984\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046105\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046091\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046090\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298996\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147904\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147907\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5951787\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046098\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046089\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046104\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046106\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13134\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13134|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=related_link\">",
"      Ceftazidime: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?34/6/34915?source=related_link\">",
"      Ceftazidime: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_4_14406="ILS histology";
var content_f14_4_14406=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63011&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63011&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histology of intralobar pulmonary sequestration",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 263px; height: 387px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Microscopic examination of an intralobar pulmonary sequestration (ILS) demonstrates large, dilated airways containing numerous muciphages. The parenchyma shows small foci of lymphocytic infiltrates and is structurally abnormal, with thickened airspace walls and poorly subdivided airspaces.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Claire Langston, MD and Christopher Oermann, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14406=[""].join("\n");
var outline_f14_4_14406=null;
var title_f14_4_14407="Estradiol and levonorgestrel: Drug information";
var content_f14_4_14407=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Estradiol and levonorgestrel: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?13/30/13798?source=see_link\">",
"    see \"Estradiol and levonorgestrel: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708750\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F167132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      ClimaraPro&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F167147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Estrogen and Progestin Combination",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F167135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of moderate-to-severe vasomotor symptoms associated with menopause or prevention of postmenopausal osteoporosis:",
"     </b>",
"     Adult females with an intact uterus:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Transdermal:",
"     </i>",
"     Estradiol 0.045 mg/levonorgestrel 0.015 mg: Apply one patch weekly",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3182137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15837938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15837939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F167114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Patch, transdermal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     ClimaraPro&reg;: Estradiol 0.045 mg and levonorgestrel 0.015 mg per 24 hours (4s) [22 cm",
"     <sup>",
"      2",
"     </sup>",
"     ; contains estradiol 4.4 mg and levonorgestrel 1.39 mg]",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F167117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Apply once weekly to a clean, dry, fold-free area of the lower abdomen; avoid application to waistline. Do not apply to irritated or broken skin. Do not apply to breasts. Rotate site with each application. Avoid touching adhesive with fingers. Hold system in place for ~10 seconds to ensure proper application. If patch falls off during the week, may reapply same patch or apply a new patch to another area of the lower abdomen. Remove patch slowly to avoid irritating the skin. Allow skin to dry for 15 minutes, then gently rub area with an oil-based cream or lotion if needed to remove any remaining adhesive. Prior to discarding, fold patch so that it sticks to itself.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F167116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Women with an intact uterus: Treatment of moderate-to-severe vasomotor symptoms associated with menopause; prevention of postmenopausal osteoporosis",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F167145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Percentages reported as greater in ClimaraPro&trade; when compared to estradiol alone:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Depression (12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Breast pain (40%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Vaginal bleeding (78%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Application site reaction (86%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Upper respiratory tract infection (28%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%: Cardiovascular: Edema (8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Other adverse events reported with",
"     <b>",
"      estrogen and/or estrogen/progestin",
"     </b>",
"     therapy: Abdominal cramps, acne, abnormal uterine bleeding, aggravation of porphyria, amenorrhea, anaphylactoid reactions, anaphylaxis, angioedema, antifactor Xa decreased, antithrombin III decreased, appetite changes, bloating, breast enlargement, breast tenderness, carbohydrate tolerance decreased, cerebral embolism, cerebral thrombosis, chloasma, cholestatic jaundice, cholecystitis, cholelithiasis, chorea, contact lens intolerance, corneal curvature steepening, cystitis-like syndrome, dizziness; factors VII, VIII, IX, X, XII, VII-X complex, and II-VII-X complex increased; endometrial hyperplasia, erythema multiforme, erythema nodosum, galactorrhea, hemorrhagic eruption, fatigue, fibrinogen increased, glucose tolerance impaired, HDL-cholesterol increased, hirsutism, hypertension, gallbladder disease, insomnia, LDL-cholesterol decreased, libido changes, melasma, migraine, nervousness, optic neuritis, pancreatitis, platelet aggregability and platelet count increased, premenstrual-like syndrome, PT and PTT accelerated, pulmonary embolism, pyrexia, retinal thrombosis, scalp hair loss, size of uterine leiomyomata increased, somnolence, thrombophlebitis, thyroid-binding globulin increased, total thyroid hormone (T",
"     <sub>",
"      4",
"     </sub>",
"     ) increased, triglycerides increased, urticaria, vaginal candidiasis, vomiting, weight gain/loss",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F167120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to estradiol, levonorgestrel, or any component of the formulation; undiagnosed abnormal vaginal bleeding; history of or current thrombophlebitis or venous thromboembolic disorders (including DVT, PE); active or recent (within 1 year) arterial thromboembolic disease (eg, stroke, MI); carcinoma of the breast; estrogen-dependent tumor; hepatic dysfunction or disease; pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F167105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Breast cancer:",
"     <b>",
"      [U.S. Boxed Warning]: Based on data from the Women&rsquo;s Health Initiative (WHI) studies, an increased risk of invasive breast cancer was observed in postmenopausal women using conjugated estrogens (CE) in combination with medroxyprogesterone acetate (MPA).",
"     </b>",
"     This risk may be associated with duration of use and declines once combined therapy is discontinued (Chlebowski, 2009). The risk of invasive breast cancer was decreased in postmenopausal women with a hysterectomy using CE only, regardless of weight. However, the risk was not significantly decreased in women at high risk for breast cancer (family history of breast cancer, personal history of benign breast disease) (Anderson, 2012). An increase in abnormal mammogram findings has also been reported with estrogen alone or in combination with progestin therapy. Estrogen use may also lead to severe hypercalcemia in patients with breast cancer and bone metastases; discontinue estrogen if hypercalcemia occurs. Use is contraindicated in patients with known or suspected breast cancer.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dementia:",
"     <b>",
"      [U.S. Boxed Warning]: Estrogens with or without progestin should not be used to prevent dementia. In the Women&rsquo;s Health Initiative Memory Study (WHIMS), an increased incidence of dementia was observed in women &ge;65 years of age taking CE alone or in combination with MPA.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Endometrial carcinoma: The use of unopposed estrogen in women with an intact uterus is associated with an increased risk of endometrial cancer. The addition of a progestin to estrogen therapy may decrease the risk of endometrial hyperplasia, a precursor to endometrial cancer. Adequate diagnostic measures, including endometrial sampling if indicated, should be performed to rule out malignancy in postmenopausal women with undiagnosed abnormal vaginal bleeding. Estrogens may exacerbate endometriosis. Malignant transformation of residual endometrial implants has been reported posthysterectomy with unopposed estrogen therapy. Consider adding a progestin in women with residual endometriosis posthysterectomy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Inherited thrombophilia: Women with inherited thrombophilias (eg, protein C or S deficiency) may have increased risk of venous thromboembolism (DeSancho, 2010; van Vlijmen, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lipid effects: Estrogen compounds are generally associated with lipid effects such as increased HDL-cholesterol and decreased LDL-cholesterol. Triglycerides may also be increased; use with caution in patients with familial defects of lipoprotein metabolism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ovarian cancer: Postmenopausal estrogen therapy and combined estrogen/progesterone therapy may increase the risk of ovarian cancer; however, the absolute risk to an individual woman is small. Although results from various studies are not consistent, risk does not appear to be significantly associated with the duration, route, or dose of therapy. In one study, the risk decreased after 2 years following discontinuation of therapy (M&oslash;rch, 2009). Although the risk of ovarian cancer is rare, women who are at an increased risk (eg, family history) should be counseled about the association (NAMS, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Retinal vascular thrombosis: Estrogens may cause retinal vascular thrombosis; discontinue if migraine, loss of vision, proptosis, diplopia, or other visual disturbances occur; discontinue permanently if papilledema or retinal vascular lesions are observed on examination.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Use caution in patients with asthma; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Carbohydrate intolerance: May have adverse effects on glucose tolerance; use caution in women with diabetes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease:",
"     <b>",
"      [U.S. Boxed Warning]: Estrogens with or without progestin should not be used to prevent cardiovascular disease.",
"     </b>",
"     Using data from the Women&rsquo;s Health Initiative (WHI) studies, an increased risk of deep vein thrombosis (DVT) and stroke has been reported with CE and an increased risk of DVT, stroke, pulmonary emboli (PE) and myocardial infarction (MI) has been reported with CE with MPA in postmenopausal women. Additional risk factors include diabetes mellitus, hypercholesterolemia, hypertension, SLE, obesity, tobacco use, and/or history of venous thromboembolism (VTE). Risk factors should be managed appropriately; discontinue use if adverse cardiovascular events occur or are suspected.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diseases exacerbated by fluid retention: Use with caution in patients with diseases which may be exacerbated by fluid retention, including cardiac or renal dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Epilepsy: Use caution with epilepsy; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gallbladder disease: Use of postmenopausal estrogen may be associated with an increased risk of gallbladder disease requiring surgery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic dysfunction: Estrogens are poorly metabolized in patients with hepatic dysfunction. Use caution with a history of cholestatic jaundice associated with prior estrogen use or pregnancy. Discontinue if jaundice develops or if acute or chronic hepatic disturbances occur. Use is contraindicated with hepatic disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic hemangiomas: Use with caution in patients with hepatic hemangiomas; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypocalcemia: Use with caution in patients with severe hypocalcemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Migraine: Use caution with migraine; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Porphyria: Use with caution in patients with porphyria; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; SLE: Use with caution in patients with SLE; may exacerbate disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid replacement therapy: Estrogens may increase thyroid-binding globulin (TBG) levels leading to increased circulating total thyroid hormone levels. Women on thyroid replacement therapy may require higher doses of thyroid hormone while receiving estrogens.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Premenopausal women: Not for use prior to menopause.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Surgical patients: Whenever possible, should be discontinued at least 4-6 weeks prior to elective surgery associated with an increased risk of thromboembolism or during periods of prolonged immobilization.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Transdermal patch: Following application, avoid exposure of the transdermal patch to prolonged periods of sunlight.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Laboratory changes: The use of estrogens and/or progestins may change the results of some laboratory tests (eg, coagulation factors, lipids, glucose tolerance, binding proteins). The dose, route, and the specific estrogen/progestin influences these changes. In addition, personal risk factors (eg, cardiovascular disease, smoking, diabetes, age) also contribute to adverse events; use of specific products may be contraindicated in women with certain risk factors.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Osteoporosis use: For use only in women at significant risk of osteoporosis and for who other nonestrogen medications are not considered appropriate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Risks vs benefits:",
"     <b>",
"      [U.S. Boxed Warning]: Estrogens with or without progestin should be used for the shortest duration possible at the lowest effective dose consistent with treatment goals.",
"     </b>",
"     Before prescribing estrogen therapy to postmenopausal women, the risks and benefits must be weighed for each patient. Women should be informed of these risks and benefits, as well as possible effects of progestin when added to estrogen therapy. Patients should be reevaluated as clinically appropriate to determine if treatment is still necessary. Available data related to treatment risks are from Women&rsquo;s Health Initiative (WHI) studies, which evaluated oral CE 0.625 mg with or without MPA 2.5 mg relative to placebo in postmenopausal women. Other combinations and dosage forms of estrogens and progestins were not studied.",
"     <b>",
"      Outcomes reported from clinical trials using CE with or without MPA should be assumed to be similar for other doses and other dosage forms of estrogens and progestins until comparable data becomes available.",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F167142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F167109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anastrozole: Estrogen Derivatives may diminish the therapeutic effect of Anastrozole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ascorbic Acid: May increase the serum concentration of Estrogen Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chenodiol: Estrogen Derivatives may diminish the therapeutic effect of Chenodiol.  Management: Monitor clinical response to chenodiol closely when used together with any estrogen derivative.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Estrogen Derivatives may increase the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Estrogenic Properties): May enhance the adverse/toxic effect of Estrogen Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Estrogen Derivatives may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving estrogens (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): May enhance the thrombogenic effect of Estrogen Derivatives. NSAID (COX-2 Inhibitor) may increase the serum concentration of Estrogen Derivatives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ospemifene: Estrogen Derivatives may enhance the adverse/toxic effect of Ospemifene. Estrogen Derivatives may diminish the therapeutic effect of Ospemifene.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: Estrogen Derivatives may increase the serum concentration of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatropin: Estrogen Derivatives may diminish the therapeutic effect of Somatropin. Shown to be a concern with oral hormone replacement therapy in postmenopausal women.  Management: Monitor for reduced growth hormone efficacy. A larger somatropin dose may be required to reach treatment goal.  This interaction does not appear to apply to non-orally administered estrogens (e.g., transdermal, vaginal ring).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: Estrogen Derivatives may diminish the therapeutic effect of Thyroid Products.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: Estrogen Derivatives may enhance the dermatologic adverse effect of Tipranavir. The combination of tipranavir/ritonavir and ethinyl estradiol/norethindrone was associated with a high incidence of skin rash. Tipranavir may decrease the serum concentration of Estrogen Derivatives.  Management: Women using hormonal contraceptives should consider alternative, non-hormonal forms of contraception.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ursodiol: Estrogen Derivatives may diminish the therapeutic effect of Ursodiol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F167122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use of this combination is contraindicated during pregnancy. Estrogens are not indicated for use during pregnancy or immediately postpartum. Increased risk of fetal reproductive tract disorders and other birth defects have been observed with diethylstilbestrol (DES). Epidemiologic studies have not shown an increased risk of birth defects when levonorgestrel is used prior to pregnancy or inadvertently during early pregnancy, although rare reports of congenital anomalies have been reported. This product is intended to be used only in postmenopausal women.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F167138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F167123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Estradiol and levonorgestrel are both excreted in breast milk. Estrogen has been shown to decrease the quantity and quality of human milk; use only if clearly needed; monitor the growth of the infant closely.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F2523889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ensure adequate calcium and vitamin D intake when used for the prevention of osteoporosis.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F3422227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Patch weekly",
"     </b>",
"     (Climara Pro Transdermal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.045-0.015 mg/day (4): $124.69",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F167112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yearly physical examination that includes blood pressure and Papanicolaou smear, breast exam, mammogram. Monitor for signs of endometrial cancer. Adequate diagnostic measures, including endometrial sampling, if indicated, should be performed to rule out malignancy in all cases of undiagnosed abnormal vaginal bleeding. Monitor for loss of vision, sudden onset of proptosis, diplopia, migraine; signs and symptoms of thromboembolic disorders; glycemic control in patients with diabetes; lipid profiles in patients being treated for hyperlipidemias; thyroid function in patients on thyroid hormone replacement therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Menopausal symptoms: Assess need for therapy at 3- to 6-month intervals",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prevention of osteoporosis: Bone density measurement",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F167104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Estrogens are responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Estradiol is the principle intracellular human estrogen and is more potent than estrone and estriol at the receptor level; it is the primary estrogen secreted prior to menopause. Following menopause, estrone and estrone sulfate are more highly produced. Estrogens modulate the pituitary secretion of gonadotropins, luteinizing hormone, and follicle-stimulating hormone through a negative feedback system; estrogen replacement reduces elevated levels of these hormones in postmenopausal women.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Levonorgestrel inhibits gonadotropin production; when used in this combination, it counteracts the proliferative effects of estradiol on the endometrium.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F167119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Estradiol and levonorgestrel: Bind to sex hormone-binding globulin and albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Estradiol: Hepatic via oxidation and conjugation in GI tract; hydroxylated via CYP3A4 to metabolites; first-pass effect; enterohepatic recirculation; reversibly converted to estrone and estriol",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Levonorgestrel: Hepatic involving CYP3A4; undergoes reduction and conjugation followed by hydroxylation; forms metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Estradiol: 3 &plusmn; 0.67 hours; Levonorgestrel: 28 &plusmn; 6.4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: Topical: Estradiol (mean): 2-2.5 days; Levonorgestrel: 2.5 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Estradiol: Primarily urine (as metabolites estrone and estriol); feces (small amounts)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Levonorgestrel: Primarily urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Anderson GL, Chlebowski RT, Aragaki AK, et al, \"Conjugated Equine Oestrogen and Breast Cancer Incidence and Mortality in Postmenopausal Women With Hysterectomy: Extended Follow-Up of the Women's Health Initiative Randomised Placebo-Controlled Trial,\"",
"      <i>",
"       Lancet Oncol,",
"      </i>",
"      2012,13(5):476-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/22401913/pubmed\" id=\"22401913\" target=\"_blank\">",
"        22401913",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Anderson GL, Limacher M, Assaf AR, et al, \"Effects of Conjugated Equine Estrogen In Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial.\"",
"      <i>",
"       JAMA",
"      </i>",
"      , 2004, 291(14):1701-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/15082697/pubmed\" id=\"15082697\" target=\"_blank\">",
"        15082697",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chlebowski RT, Kuller LH, Prentice RL, et al, \"Breast Cancer After Use of Estrogen Plus Progestin in Postmenopausal Women,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2009, 360(6):573-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/19196674/pubmed\" id=\"19196674\" target=\"_blank\">",
"        19196674",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DeSancho MT, Dorff T, and Rand JH, \"Thrombophilia and the Risk of Thromboembolic Events In Women on Oral Contraceptives and Hormone Replacement Therapy,\"",
"      <i>",
"       Blood Coagul Fibrinolysis",
"      </i>",
"      , 2010, 21(6):534-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/20581664/pubmed\" id=\"20581664\" target=\"_blank\">",
"        20581664",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hsia J, Langer RD, Manson JE, et al, \"Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative,\"",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 2006, 166(3):357-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/16476878/pubmed\" id=\"16476878\" target=\"_blank\">",
"        16476878",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      M&oslash;rch LS, L&oslash;kkegaard E, Andreasen AH, et al, &ldquo;Hormone Therapy and Ovarian Cancer,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2009, 302(3):298-305.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/19602689/pubmed\" id=\"19602689\" target=\"_blank\">",
"        19602689",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      North American Menopause Society [NAMS], \"The 2012 Hormone Therapy Position Statement of The North American Menopause Society,\"",
"      <i>",
"       Menopause",
"      </i>",
"      , 2012, 19(3):257-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/22367731/pubmed\" id=\"22367731\" target=\"_blank\">",
"        22367731",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rossouw JE, Anderson GL, Prentice RL, et al, &ldquo;Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principle Results From the Women's Health Initiative Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2002, 288(3):321-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/12117397/pubmed\" id=\"12117397\" target=\"_blank\">",
"        12117397",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shumaker SA, Legault C, Rapp SR, et al, &ldquo;Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(20):2651-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/12771112/pubmed\" id=\"12771112\" target=\"_blank\">",
"        12771112",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      U.S. Food and Drug Administration, Department of Health and Human Services, &ldquo;WHIMS Study on Estrogen/Progestin,&rdquo; May 27, 2003. Available at",
"      <a href=\"file://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm135318.htm\" target=\"_blank\">",
"       file://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm135318.htm",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van Vlijmen EF, Veeger NJ, Middeldorp S, et al, \"Thrombotic Risk During Oral Contraceptive Use and Pregnancy in Women With Factor V Leiden or Prothrombin Mutation: A Rational Approach to Contraception,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 2011, 118(8):2055-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/4/14407/abstract-text/21659542/pubmed\" id=\"21659542\" target=\"_blank\">",
"        21659542",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8862 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-09444732DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14407=[""].join("\n");
var outline_f14_4_14407=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708750\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167132\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167147\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167135\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3182137\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15837938\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15837939\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167114\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167117\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167116\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167145\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167120\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167105\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167142\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167109\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167122\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167138\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167123\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2523889\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422227\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167112\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167104\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167119\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8862\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8862|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/30/13798?source=related_link\">",
"      Estradiol and levonorgestrel: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_4_14408="Bio pathways thera targets in RCC";
var content_f14_4_14408=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F65979&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F65979&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 600px\">",
"   <div class=\"ttl\">",
"    Biological pathways and the resulting therapeutic targets in renal cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 580px; height: 423px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In conditions of normoxia and normal VHL gene function, von Hippel-Landau protein is the substrate recognition component of an E3 ubiquitin ligase complex that targets hypoxia-inducible factor (HIF) for proteolysis. In cellular hypoxia or with an inactivated VHL gene, the VHL proteinHIF interaction is disrupted, leading to stabilisation and accumulation of HIF transcription factors. HIF accumulation can also result from activation of the mammalian target of rapamycin (mTOR) through cellular stimuli and the phosphoinositide 3-kinase (PI3K)/Akt (protein kinase) pathway. mTOR phosphorylates and activates p70S6 kinase (p70S6K) leading to enhanced translation of certain proteins, including HIF. Activated mTOR also phosphorylates 4E binding protein-1 (4E-BP1), promoting dissociation of this complex and allowing eukaryotic initiation factor-4 subunit E (eIF-4E) to stimulate an increase in the translation of mRNAs that encode cell-cycle regulators such as c-myc and cyclin D1. Activated HIF translocates into the nucleus and leads to transcription of a large range of hypoxia-inducible genes, including vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). These ligands bind to their cognate receptors present on the surface of endothelial cells, leading to cell migration, proliferation, and permeability. Temsirolimus binds to FK506-binding protein (FKBP), and the resultant proteindrug complex inhibits the kinase activity of the mTOR complex 1 (mTORC1). Bevacizumab is a VEGF ligand-binding antibody. Sunitinib and sorafenib are small molecule inhibitors of the VEGF receptor (VEGFR) and PDGF receptor (PDGRF) tyrosine kinases.",
"    <div class=\"footnotes\">",
"     PTEN: phosphatase and tensin homologue; Pro: proline; Ub: ubiquitin.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009; 373:1119. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14408=[""].join("\n");
var outline_f14_4_14408=null;
var title_f14_4_14409="Clinical and laboratory diagnosis of seizures in infants and children";
var content_f14_4_14409=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical and laboratory diagnosis of seizures in infants and children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/4/14409/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/4/14409/contributors\">",
"     Angus Wilfong, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/4/14409/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/4/14409/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/4/14409/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/4/14409/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/4/14409/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;This review highlights the aspects of the physical and neurologic examination, imaging studies, and laboratory investigation that are relevant to the assessment of the infant and child with epilepsy. The detailed pediatric neurologic examination, acute illnesses accompanied by seizures, and febrile seizures are discussed separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of children with epilepsy have an idiopathic disorder with a normal neurologic examination and neuroimaging studies. Thus, a careful history is the cornerstones of an accurate diagnosis. A detailed account of the child's behavior preceding, during, and following a \"spell\" is critical. This account may require a follow-up visit with witnesses or a phone call to individuals, such as a teacher, who actually saw the \"seizure.\" The physician should remember to include the child in the conversation; quite often the child provides valuable information.",
"   </p>",
"   <p>",
"    The physician can ask the parent or witness to mime the event, or the physician can mimic different kinds of seizures to find a match for the child's episodes. Often the family or the initial physician involved with the child will describe the episode as simply a \"grand mal\" or \"petit mal\" seizure. Frequently, the physician is told that the child had \"staring episodes\" or \"fell down and shook all over.\" These descriptions are not adequate for arriving at a definite diagnosis.",
"   </p>",
"   <p>",
"    The physician should not accept a previous diagnosis of \"epilepsy\" without taking the child's history. The historians should be asked to describe the seizures in degree of severity (ie, the mildest to the most severe). Often the large seizures (ie, generalized tonic-clonic) are preceded by the identical symptoms that occur in the minor ones, confirming the suspicion of a partial or focal seizures with secondary generalization. However, some children have two or more seizure types. The brief focal signs or aura prior to the more dramatic event, or the important localizing symptoms following the seizure, may be missed in a cursory history. A generalized tonic-clonic seizure may be preceded by brief twitching of one side of the face and followed by a transient language disorder consistent with a dysphasia, supporting the diagnosis of a partial seizure arising in the dominant hemisphere, with secondary generalization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Setting in which episodes occur",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most seizures occur at random and without warning. In contrast, many nonepileptic spells have characteristic precipitating circumstances or occur in specific locations. Determining the time of day and the activity in which the child was engaged prior to the seizure is important.",
"   </p>",
"   <p>",
"    Important questions to consider include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Were the seizures primarily nocturnal and, if so, what time of the night did they occur?",
"     </li>",
"     <li>",
"      Was the child taking medication (prescription and over-the-counter) or herbal substances prior to the seizure? Several herbal supplements, including St. John's wort, MaHuang, and Kava kava have caused seizures [",
"      <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Did the seizures occur only with illness and fever? Seizures occurring in the setting of fever alone may represent febrile seizures, rather than epilepsy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=see_link\">",
"       \"Febrile seizures\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Did the seizure occur in the setting of other acute medical events (eg, acute head injury, other acute medical illness)? Such seizures may be provoked and at lower risk of recurrence than nonprovoked seizures. As an example, in one study, children who had a seizure in the setting of acute gastroenteritis had a particularly low risk of seizure recurrence compared to other children with a first seizures (HR = 0.28) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Did the seizures occur only when the child was relaxed and never occur when actively involved in some type of activity? (More likely nonseizure events).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Behavior immediately prior to the event",
"    </span>",
"    &nbsp;&mdash;&nbsp;On rare occasions, seizures may be precipitated by environmental stimuli such as sound or an unexpected touch (reflex epilepsy). More commonly, no obvious precipitating circumstances are present. Thus, obtaining a history of the events leading up to the seizure is important because they may be more suggestive of a non-seizure diagnosis.",
"   </p>",
"   <p>",
"    Important questions to consider include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Do the episodes always occur when the child is upset and crying (cyanotic breath-holding spells); only after a minor blow to the head or upper torso (pallid infantile syncope); only in the classroom and never seen by the parents (staring episodes are commonly seen in children with attention deficit hyperactivity disorder); or always when standing and preceded by nausea and dizziness (simple vasovagal syncope)? (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29175?source=see_link\">",
"       \"Nonepileptic paroxysmal disorders in children\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      What activity was the patient engaged in immediately prior to the seizure? Does the patient mention any sensory or autonomic symptoms (numbness, visual distortions, auditory or visual hallucinations or illusions, nausea or unusual feelings in the abdomen or chest, an unusual smell or taste, etc) or manifest an alteration in behavior or mood?",
"     </li>",
"     <li>",
"      Did a loss of appetite, nausea, vomiting, or headache occur before or after the seizure? Headaches are not uncommon after a generalized convulsive seizure but are infrequent before a seizure [",
"      <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/3\">",
"       3",
"      </a>",
"      ]. Nausea and vomiting more often are seen in association with a migraine syndrome, which can mimic a seizure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29175?source=see_link\">",
"       \"Nonepileptic paroxysmal disorders in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Are the seizures precipitated by a particular stimulus? Seizures are rarely precipitated by mild trauma. Pallid infantile syncope is a common benign pediatric syndrome characterized by sudden transient bradycardia followed by an anoxic seizure (with pallor) and spontaneous recovery that are precipitated by a mild unexpected blow to the head and upper torso. It is caused by excessive vagal tone and is of unknown etiology. Pointed questioning may be necessary to uncover the history of mild trauma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29175?source=see_link\">",
"       \"Nonepileptic paroxysmal disorders in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Were focal signs or symptoms present? Examples include face or extremity twitching, an illusion of a bad smell or taste, and a deja-vu experience. Some of these symptoms are considered an \"aura,\" or a simple partial seizure, which may be the first clinical manifestation of the seizure. This information can be valuable for localizing the epileptic focus [",
"      <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]. Patients may not remember these symptoms because retrograde amnesia often accompanies seizures, particularly those with generalized motor activity.",
"     </li>",
"     <li>",
"      Does the child predictably cry before a seizure? In studies of adults, weeping during an event was typical of a nonepileptic seizure [",
"      <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/6\">",
"       6",
"      </a>",
"      ]. Consistent crying before a \"seizure\" is suggestive of a cyanotic breath-holding spell.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Physical description",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physician should obtain a description of the patient's color during the event and determine whether anyone checked the child's heart rate or pulse. Anoxic nonepileptic seizures may be secondary to a cardiac arrhythmia. If a child has a color change during a seizure, particularly a generalized motor seizure,",
"    <span class=\"nowrap\">",
"     he/she",
"    </span>",
"    usually will become cyanotic. A cardiac cause for the event should be considered if the child is described as pale. A description of forceful eye or head deviation to one side can be a useful localizing feature.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Behavior during the event",
"    </span>",
"   </p>",
"   <p>",
"    Important questions to consider include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Are limb movements unilateral, bilateral, synchronous, clonic (rhythmic flexion movements or rhythmically interrupted tonus), or irregular and thrashing? Bilateral motor seizures, particularly those involving all the extremities and the trunk with generalized, relatively symmetric, tonic or clonic movements, are usually associated with altered consciousness. A nonepileptic seizure should be suspected if the patient has generalized motor activity with normal responsiveness, particularly if it lasts longer than 5 minutes. Prolonged waxing and waning of clonic or tonic activity or stimulus-provoked",
"      <span class=\"nowrap\">",
"       clonic/tonic",
"      </span>",
"      activity during a generalized motor seizure is more consistent with a nonepileptic seizure. Repeatedly and consistently stereotyped behaviors suggest seizures as compared to nonepileptic events.",
"     </li>",
"     <li>",
"      Are the eyes and mouth closed? A nonepileptic seizure should be considered if the patient keeps the eyes tightly closed during the seizure and, particularly, if passive eye opening is actively resisted [",
"      <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. Sustained eye deviation or nystagmoid eye movements are relatively subtle clinical manifestations of seizure activity. Patients with true generalized motor seizures tend to keep their mouths open during the tonic phase of the seizure; in generalized motor nonepileptic seizures, the mouth is partially or tightly closed (clenched).",
"     </li>",
"     <li>",
"      What was the patient's response to verbal commands, pinching, or more painful stimulation? Generalized motor seizures cannot be interrupted by vocal or",
"      <span class=\"nowrap\">",
"       tactile/painful",
"      </span>",
"      stimulation. In contrast, a patient with a nonepileptic seizure may suddenly return to normal after a painful stimulus or shouting of his or her name. However, an abrupt return to consciousness is often seen in frontal lobe seizures and should not be considered a reliable sign of nonepileptic seizures.",
"     </li>",
"     <li>",
"      What was the duration of the event? Most seizures are short-lived; an episode of confusion or loss of contact with the environment that lasts more than five minutes should raise the suspicion of a nonepileptic event.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Behavior after the event",
"    </span>",
"   </p>",
"   <p>",
"    Important questions to consider include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      What was the patient's behavior after the event (postictal state)? Did he or she recover immediately, or was there confusion or somnolence? Was the child able to communicate verbally immediately after the event (eg, could the patient form appropriate and full sentences; was the child oriented; could the child follow complex or simple verbal commands)?",
"     </li>",
"     <li>",
"      Were there focal findings during the postictal state, such as a hemiparesis (Todd's paralysis)? These features are helpful for localization. As an example, if a child had a generalized motor seizure, but in the postictal period could not talk despite being able to follow simple commands (postictal dysphasia), a focal onset in the speech area of the dominant hemisphere would be suspected.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Neuropsychological and social assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epilepsy is often accompanied by cognitive and developmental delay, including autism [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/9-13\">",
"     9-13",
"    </a>",
"    ]. One study compared 282 children with normal IQ and a first recognized seizure to 147 healthy siblings and found that children with seizures scored lower on all neuropsychological tests; 27 percent had a neuropsychological deficit [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/9\">",
"     9",
"    </a>",
"    ]. Risk factors for neuropsychological impairment included a",
"    <span class=\"nowrap\">",
"     symptomatic/cryptogenic",
"    </span>",
"    etiology, a second unprovoked seizure, use of antiepileptic drugs, and epileptiform activity on the initial electroencephalogram (EEG). When developmental delay",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intellectual impairment is overt, the child should be referred for appropriate evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26793?source=see_link\">",
"     \"Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/8/5257?source=see_link\">",
"     \"Intellectual disability (mental retardation) in children: Evaluation\"",
"    </a>",
"    .) The most appropriate method of screening other children with epilepsy for intellectual impairments is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with epilepsy are also more likely to have psychiatric disorders such as depression, anxiety, and attention deficit hyperactivity disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/12\">",
"     12",
"    </a>",
"    ]. Specific assessment and management of these conditions is likely to be beneficial in the child&rsquo;s overall prognosis.",
"   </p>",
"   <p>",
"    The psychological stresses associated with epilepsy can be the major problem confronting the child or family. Health-related quality of life (HRQOL) can be affected even after a single seizure; but overall, deficits in HRQOL in children with epilepsy are related to seizure frequency and severity, as well as socioeconomic status [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. The child may have difficulty at school because of peer ridicule, a poor academic performance as a result of limited cognitive function, low self esteem,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    depression. The patient's mental health should be specifically addressed at regular follow-up evaluations, and the appropriate referral to a mental health specialist considered if significant issues are uncovered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other elements of the history",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A developmental history should be obtained, with particular attention given to any plateau or loss of developmental milestones. In older children, a history of academic performance and social interactions are also essential parts of the history.",
"     </li>",
"     <li>",
"      The examiner should search for a history of previous illnesses that are associated with seizures (eg, meningitis, hypoxic-ischemic encephalopathy, head trauma).",
"     </li>",
"     <li>",
"      A detailed family history is mandatory. Consanguinity should raise a suspicion of an inherited disorder, particularly a recessively-inherited inborn error of metabolism. A family history of seizures may suggest a dominantly inherited epileptic disorder.",
"     </li>",
"     <li>",
"      The teenager with seizures should be questioned about drug use. A random drug screen might be considered if illicit drug use or withdrawal is suspected as a cause of seizures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general history and physical examination of children with seizures includes several elements.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In addition to searching for medical causes of the patient's seizures, close attention should be paid to the eye examination. The physician should look for congenital ocular defects, the retinal changes associated with certain neurocutaneous and neurodegenerative disorders, or signs of an earlier infection. Ophthalmology consultation should be obtained if the funduscopic examination is difficult, as in the active infant.",
"     </li>",
"     <li>",
"      The abdominal examination may reveal hepatosplenomegaly, suggesting a storage disease.",
"     </li>",
"     <li>",
"      A cardiac examination, including an ECG, is necessary if concern exists about a cardiogenic cause for the patient's episodes. Episodes of disturbed neurologic function caused by decreased cardiac output (eg, prolonged QT syndrome or pulmonary hypertension) may closely mimic complex partial seizures, including the presence of an aura [",
"      <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/19\">",
"       19",
"      </a>",
"      ].A genetic assessment is important. Dysmorphic features and other congenital anomalies, body asymmetries, and unusual skull shapes should be noted. As an example, we see many children with a referral diagnosis of cerebral palsy and epilepsy who have the obvious and often striking clinical and dysmorphic features of Angelman syndrome, a chromosomal disorder caused by a deletion of chromosome 15q12.",
"     </li>",
"     <li>",
"      The skin examination is of particular importance in the evaluation of children with seizures as many neurocutaneous disorders are associated with epilepsy. The cutaneous features of tuberous sclerosis, the facial angioma of Sturge-Weber syndrome, the caf&eacute;-au-lait spots of neurofibromatosis, the nevi of the linear nevus syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/20\">",
"       20",
"      </a>",
"      ], and the swirling hypopigmentation of Ito syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/21\">",
"       21",
"      </a>",
"      ] all are characteristic physical findings. Wood's lamp examination to identify the hypopigmented macules (ash leaf spots) of tuberous sclerosis is an essential feature of the examination of a child with seizures. Dermatological consultation should be considered in a child with seizures who has a skin lesion that cannot be identified easily. Most neurocutaneous disorders are hereditary and, if identified, should lead to family counseling and possibly genetic consultation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ELECTROENCEPHALOGRAM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electroencephalogram (EEG) is a valuable adjunct to the assessment of children with suspected seizures. Virtually every child with recurrent seizures should have an EEG awake and while sleeping. Each EEG recording should be performed with specific questions in mind, an understanding and anticipation of the possible results, and a planned response to these results.",
"   </p>",
"   <p>",
"    The value of the EEG interpretation is related directly to the interpretive skills of the electroencephalographer. Only individuals with significant pediatric experience are able to recognize the characteristic features of a benign epileptic disorder and differentiate it from more serious syndromes. A phone consultation with the electroencephalographer prior to the EEG often is helpful in planning the study. Obtaining an EEG recording during sleep and wakefulness and optimizing the timing of the EEG will help maximize the chances of finding epileptiform activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Sleep EEG",
"    </span>",
"    &nbsp;&mdash;&nbsp;An awake and asleep EEG should always be obtained. Epileptiform activity may appear in only one state (usually sleep). Even if epileptiform activity is evident on the initial awake tracing, a sleep recording is indicated. As an example, in the benign partial epilepsies, focal or multifocal spike and slow wave discharges, which are diagnostic of these syndromes, typically appear only during drowsiness and light sleep. In these children, fragments of generalized spike and wave activity can be seen during wakefulness and may erroneously suggest a generalized epilepsy. The benign focal epilepsy syndromes may also manifest a photoparoxysmal response (epileptiform activity provoked by repetitive light flashes), however, these are more typically are seen in the idiopathic generalized epilepsies.",
"   </p>",
"   <p>",
"    The child should be allowed to sleep naturally in the EEG laboratory. If necessary, mild sedation (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/38/2662?source=see_link\">",
"     chloral hydrate",
"    </a>",
"    ) can be used. Many laboratories use sleep deprivation by requesting that the child is kept up a significant portion of the night prior to the EEG. However, while this technique increases the likelihood of recording sleep, studies suggest that it may not increase the chance of finding epileptiform activity in children [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/22,23\">",
"     22,23",
"    </a>",
"    ], although it may in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32425?source=see_link\">",
"     \"Electroencephalography (EEG) in the diagnosis of seizures and epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While sleep deprivation, increases the likelihood of detecting epileptiform discharges, even in the absence of recording sleep, the increased yield is modest. One study found that 11 sleep-deprived EEGs would be required to identify one additional child with epileptiform discharges compared to a routine EEG [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/23\">",
"     23",
"    </a>",
"    ]. Sleep-deprivation can be a difficult task for parents, and sleep-deprived children, particularly those with cognitive impairment or behavioral disorders, can be difficult to manage in the EEG laboratory [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/25\">",
"     25",
"    </a>",
"    ]. In one case series the diagnostic yield of a sleep-deprived EEG was similar to that of an EEG obtained within 24 hours of a seizure [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Federal regulations on \"conscious sedation\" render use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/38/2662?source=see_link\">",
"     chloral hydrate",
"    </a>",
"    for EEG laboratories difficult. Hence, many laboratories have resorted to using partial sleep deprivation (keeping the child up beyond bedtime, awakening early, and preventing sleep on the way to the laboratory) as the most effective means of attaining adequate sleep during the recording session [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Timing of the EEG",
"    </span>",
"    &nbsp;&mdash;&nbsp;The EEG should be obtained as soon as possible after a seizure, particularly if an initial EEG was normal [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/28\">",
"     28",
"    </a>",
"    ]. In most patients, the incidence of epileptiform discharges is highest in the first 24 hours after a seizure [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/26\">",
"     26",
"    </a>",
"    ]. In some children, however, the EEG immediately after a seizure will be normal or will show nonspecific background abnormalities (postictal slowing) but no epileptiform activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Obtaining repeat EEGs",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the diagnosis is still in question after the initial EEG, a repeat tracing should be done. One group found the initial EEG to be normal in 44 percent of 552 children ages one month to 16 years with one or more newly diagnosed idiopathic or remote symptomatic seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/29\">",
"     29",
"    </a>",
"    ]. When the EEG was repeated with sleep deprivation in 177 children with an initially normal EEG, epileptiform abnormalities were found in 61 (35 percent), increasing the yield of an abnormal test by 11 percent.",
"   </p>",
"   <p>",
"    Attempts should be made to obtain the repeat EEG at a time when the child is most likely to have a seizure. As an example, the EEG should be done in the morning if seizures are occurring primarily in the morning upon awakening (as often occurs in juvenile myoclonic epilepsy). If the seizures are nocturnal (as often occurs in frontal lobe and benign rolandic epilepsy), an all-night sleep recording in the laboratory or an ambulatory EEG should be considered.",
"   </p>",
"   <p>",
"    More than three repeat EEGs adds little further information [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/30\">",
"     30",
"    </a>",
"    ]. Up to 30 to 50 percent of children with epilepsy will be \"EEG-negative.\" In patients with serial negative EEGs and an undiagnosed paroxysmal disorder, inpatient video-EEG or ambulatory EEG recording can be helpful. Before considering one of these more expensive procedures, the case should be discussed with an epileptologist to maximize the chances of obtaining useful information on the EEG and to explore other possibilities in the differential diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Use of the EEG to determine the type of epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interictal epileptiform pattern on the EEG is often used to determine the epilepsy syndrome and consequently the class of AED used for treatment. As examples, medications such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/36/5706?source=see_link\">",
"     carbamazepine",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/46/16104?source=see_link\">",
"     oxcarbazepine",
"    </a>",
"    often are used for partial epilepsies, whereas valproic acid,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/34/3626?source=see_link\">",
"     lamotrigine",
"    </a>",
"    , or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/34/2598?source=see_link\">",
"     ethosuximide",
"    </a>",
"    are preferred for the generalized epilepsies. However, the EEG pattern should not be used exclusively to make this decision. The detailed clinical description of the child's behavior during a seizure is equally, if not more, important than is the EEG in selecting an AED. The EEG may contain different epileptiform patterns in different states (for example, generalized spike and wave activity or a photoparoxysmal response during wakefulness and an active focal spike during light sleep).",
"   </p>",
"   <p>",
"    The danger of using EEG alone to make the diagnosis of the type of epilepsy was illustrated in a study of all children diagnosed in Nova Scotia with epilepsy onset between 1977 and 1985 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/31\">",
"     31",
"    </a>",
"    ]. The results of the EEG at the time of diagnosis were compared with a second EEG within six months in 159 children. In children with first EEG that was abnormal, a 40 to 70 percent discordance existed for the type of abnormality (focal versus generalized discharges) in the second EEG. Similarly, a retrospective analysis of 493 EEGs in 180 patients with idiopathic generalized epilepsy found that first EEGs were normal in 45 percent, and only 33 percent had typical abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The differences between the two EEGs may reflect timing of the EEG in relationship to the last seizure; the amount of sleep versus wakefulness during the recording; different times of the day of the two recordings; the progression of the underlying encephalopathy causing the seizures; and the evolution of the underlying epilepsy syndrome over time; as well as direct medication effects, including withdrawal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Abnormal EEGs in healthy children",
"    </span>",
"    &nbsp;&mdash;&nbsp;EEGs of many healthy children without seizures contain epileptiform activity. In one study, epileptiform discharges were noted in 53 of 1,057 (5 percent) normal school children ages 6 to 12 years [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/33\">",
"     33",
"    </a>",
"    ]. In a second report, epileptiform abnormalities were found in 131 of 3,726 normal children (3.5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/34\">",
"     34",
"    </a>",
"    ]. Follow-up studies over an eight-to-nine-year period showed that only 7 individuals subsequently developed epilepsy. The most common abnormalities were centrotemporal spikes (37 cases) and generalized spike and wave discharges (10 cases). There was a history of febrile seizures in 19 percent of the children with epileptiform discharges, and in 9 percent of those without EEG abnormalities. A higher incidence of epileptiform activity was also noted in the families, particularly the siblings, of children with idiopathic epilepsy, as well as in children with transient metabolic or other acute illnesses. With digital EEG recordings, the prevalence may be higher; in one prospective case series, 6.5 percent of 382 healthy children (except for recent mild head trauma) had epileptiform discharges on routine EEG [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     NEUROIMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial investigation should be directed toward finding a structural abnormality as the basis of the seizures, thereby avoiding expensive laboratory tests for the less common inherited neurometabolic, degenerative, or developmental disorders. Eight broad categories of structural abnormality associated with chronic epilepsy include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neoplastic",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Malformative/genetic",
"      </span>",
"     </li>",
"     <li>",
"      Metabolic",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Familial/neurocutaneous",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Vascular/hypoxic-ischemic",
"      </span>",
"     </li>",
"     <li>",
"      Traumatic",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Infectious/inflammatory",
"      </span>",
"     </li>",
"     <li>",
"      Hippocampal",
"      <span class=\"nowrap\">",
"       sclerosis/deformation",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most common structural abnormalities found on magnetic resonance imaging (MRI) in children with epilepsy are congenital malformations, neurocutaneous syndromes, neoplasms, and evidence of a static encephalopathy following trauma, infection, or hypoxic-ischemic insult. In one case series of 150 children with a first afebrile, unprovoked seizure, significant MRI abnormalities were present in 16 percent and were associated with a significant increased risk of seizure recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/36\">",
"     36",
"    </a>",
"    ]. A community-based study of 518 children with epilepsy also revealed a 16 percent incidence of relevant MRI abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI is the preferred neuroimaging study for the evaluation of a child with seizures. MRI is more sensitive than CT for detecting brain malformations and dysplastic lesions, as well as subtle temporal lobe pathology, particularly in the hippocampus, a common site of seizure onset [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/38\">",
"     38",
"    </a>",
"    ]. Gadolinium contrast is not routinely requested, but is used when tumor, vascular malformation, inflammation, or infection is suspected based on clinical information or review of noncontrast study [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/39\">",
"     39",
"    </a>",
"    ]. Special thin cuts and imaging angles are necessary to adequately assess hippocampal anatomy and are part of the standard MRI \"seizure protocol\" (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/49/13082?source=see_link&amp;anchor=H6#H6\">",
"     \"Neuroimaging in the evaluation of seizures and epilepsy\", section on 'Epilepsy protocol for MRI'",
"    </a>",
"    ). Special MRI sequences are required in children younger than two years as immature myelination patterns may obscure some pathologies [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/39\">",
"     39",
"    </a>",
"    ]. MRI in these younger patients should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sagittal, axial, and coronal T1-weighted sequences in children one to two years of age",
"     </li>",
"     <li>",
"      Sagittal, axial, and coronal high-resolution T2-weighted sequences in children less than one year of age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the MRI is normal in children less than two years of age and seizures persist, a follow-up study after 30 months of age may allow for visualization of an underlying cortical dysplasia when more mature myelination patterns have developed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/39\">",
"     39",
"    </a>",
"    ]. This should be considered when seizures are intractable.",
"   </p>",
"   <p>",
"    In children with temporal lobe epilepsy, MRI abnormalities (eg, hippocampal sclerosis, tumor, cortical dysplasia) are associated with a higher likelihood of medical intractability [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/40\">",
"     40",
"    </a>",
"    ]. While computed tomography (CT) scan is better than MRI in identifying calcifications associated with congenital infections (eg, cytomegalovirus and toxoplasmosis) and some of the neurocutaneous syndromes (eg, tuberous sclerosis), MRI is usually also abnormal in these settings.",
"   </p>",
"   <p>",
"    A CT scan is most often used for emergency department assessment. In the setting of a first seizure, a noncontrast CT scan reveals finding that change acute management in 3 to 9 percent of children and infants [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/38,41\">",
"     38,41",
"    </a>",
"    ]. Infants less than six months of age will have a clinical relevant abnormality on CT scan 50 percent of the time.",
"   </p>",
"   <p>",
"    As mentioned above, neuroimaging may not be necessary in children who have an obvious cause for their seizures identified on the history and physical examination. In addition, children with clearly benign epilepsy based upon the history, family history, and EEG may also not need imaging studies. Most other children with seizures should have an MRI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     LABORATORY TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a child presents with a first seizure, the initial evaluation is directed toward uncovering a potential medical etiology. If an acute cause cannot be found, the child may be experiencing the initial seizure of an epileptic disorder. A discussion of the numerous tests indicated in the search for an underlying etiology of acute seizures is beyond the scope of this section. This section will emphasize the more common studies performed in the child with seizures of unknown etiology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Who should be tested?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extensive diagnostic testing may not be necessary if the history and physical examination provide an obvious etiology for the seizure. As an example, the infant with a history of pneumococcal meningitis and persistent seizures does not need extensive metabolic or genetic testing, although baseline laboratory examinations are indicated prior to initiating anticonvulsant therapy.",
"   </p>",
"   <p>",
"    Similarly, the normal child with nocturnal generalized seizures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diurnal simple partial seizures involving the face and upper extremity whose EEG shows bilateral, independent centrotemporal spike and wave discharges, particularly if a family history of seizures exists, may not have to undergo imaging studies. The diagnosis of benign childhood epilepsy with centrotemporal spikes (benign rolandic epilepsy of childhood) can be made without these studies.",
"   </p>",
"   <p>",
"    An extensive laboratory metabolic investigation may be withheld until the course of the epilepsy is better defined. A child with an inherited neurometabolic disorder is not likely to continue to have seizures, remain cognitively and developmentally normal, and have entirely normal EEG background patterns for several years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Laboratory screening in undiagnosed epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If history and physical examination and MRI do not reveal an etiology for seizures, the child should be evaluated for potential underlying metabolic, genetic, or neurodegenerative disorders. Initial studies to consider in infants and children with unexplained seizures, particularly those with developmental delay and abnormal neurologic examination include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Serum (and CSF) amino acid analysis",
"     </li>",
"     <li>",
"      Urine for quantitative organic acids",
"     </li>",
"     <li>",
"      Serum calcium, glucose, liver function tests",
"     </li>",
"     <li>",
"      Serum acylcarnitine profile, ammonia, lactate and pyruvate",
"     </li>",
"     <li>",
"      Chromosomal karyotype",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a retrospective review of patients with refractory epilepsy and developmental delay, metabolic abnormalities were identified in more than 70 percent of those without a previously identified diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/42\">",
"     42",
"    </a>",
"    ]. Multifocal interictal epileptiform discharges were associated with a finding of metabolic abnormality.",
"   </p>",
"   <p>",
"    Virtually all chromosomal syndromes can manifest seizures. Another consideration in this regard is DNA analysis for fragile X syndrome in both boys and girls with maternal family histories of mental retardation. Approximately 20 percent of males with fragile X syndrome have seizures, and female carriers of fragile X syndrome, even some with normal intelligence, can have seizures with focal EEG abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. More sophisticated genetic analyses such as FISH studies and chromosomal microarrays may be needed to diagnose those syndromes missed on routine karyotype analysis, such as Angelman and Rett syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34889?source=see_link\">",
"     \"Clinical features and diagnosis of fragile X syndrome in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a neurodegenerative disorder is suggested by the clinical or family history or parental consanguinity, further studies, including lysosomal enzymes, long-chain fatty acids (for peroxisomal disorders), and other biochemical analyses, are indicated, usually in consultation with a child neurologist",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pediatric geneticist. The cerebrospinal fluid (CSF) should be examined for routine chemistries (protein, glucose) as well as lactate and amino acids. A tube should be frozen if needed for future measurement of metabolites and neurotransmitters associated with rare neurometabolic disorders.",
"   </p>",
"   <p>",
"    A low CSF glucose in a child with no symptoms of infection and an otherwise normal CSF profile often is ignored, but may be the critical laboratory finding in the diagnosis of a rare disorder called glucose transporter protein syndrome (GLUT1 deficiency syndrome), which has a deficiency of the enzyme necessary for the transport of glucose into the CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Diagnosis can be confirmed by a erythrocyte glucose uptake assay which shows low uptake [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/48\">",
"     48",
"    </a>",
"    ].",
"    <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/books/n/gene/glossary/def-item/molecular-genetic-testing/\">",
"     Molecular genetic testing",
"    </a>",
"    for",
"    <em>",
"     SLC2A1",
"    </em>",
"    can also be used to identify some of these patients. Infants with this disorder have slowly progressive neurologic deterioration, seizures (often absence-type), and occasionally microcephaly [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Although few cases have been reported, it is probably under-detected. Glucose load may bring about transient improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/47\">",
"     47",
"    </a>",
"    ]. Children with this disorder are treated with the ketogenic diet. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/30/15850?source=see_link\">",
"     \"The ketogenic diet\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     GENETIC TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic testing is increasingly available for a number of inherited syndromes but has variable clinical utility depending on clinical and genetic heterogeneity of a particular syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?14/4/14409/abstract/51\">",
"     51",
"    </a>",
"    ]. Further information is available at",
"    <a class=\"external\" href=\"file://www.genetests.org/\">",
"     file://www.genetests.org",
"    </a>",
"    . Counseling for genetic testing is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=see_link\">",
"     \"Genetic counseling and testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/0/18434?source=see_link\">",
"       \"Patient information: EEG (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/26/419?source=see_link\">",
"       \"Patient information: Seizures in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The assessment of an infant or child with possible seizures or epilepsy includes a detailed history of events that include (see",
"      <a class=\"local\" href=\"#H2\">",
"       'History'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The setting in which episodes occur",
"     </li>",
"     <li>",
"      Behavior immediately prior to, during, and after the episode",
"     </li>",
"     <li>",
"      A physical description of the child before, during, and after the episode",
"     </li>",
"     <li>",
"      Frequency and duration of the episode",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other important aspects of the history include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      An neurodevelopmental history",
"     </li>",
"     <li>",
"      A past and current psychosocial history, including potential stressors",
"     </li>",
"     <li>",
"      A family history",
"     </li>",
"     <li>",
"      A medical history, emphasizing conditions known to be associated with epilepsy (CNS infection, trauma, etc)",
"     </li>",
"     <li>",
"      Prescription and illicit drugs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In addition to a detailed neurologic examination that includes a neuropsychiatric assessment, the general medical examination is also important in the evaluation of a child with possible seizures and epilepsy, and should include a careful eye and skin examination. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An EEG is recommended in the evaluation of a child with suspected seizures or epilepsy. In addition to providing support for the diagnosis of epilepsy, the EEG also helps define the epilepsy syndrome and directs optimal therapy. Obtaining a tracing in the awake and sleep states, in close proximity to an event, and repeating the tracing can increase the diagnostic yield of the study. Nonetheless, the sensitivity and specificity of EEG is imperfect. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Electroencephalogram'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A neuroimaging study is recommended in a child who has had an epileptic seizure. A magnetic resonance imaging study (MRI) has superior sensitivity for detecting those lesions that cause seizures. Computed tomography (CT) may be used in the emergency department evaluation of a child with seizures. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory testing is used to uncover a medical etiology for seizures. Extensive testing may not be necessary if the history and physical examination provide an obvious etiology. An initial screening metabolic test panel may be indicated in some cases. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genetic testing is increasingly available for a number of inherited syndromes but has variable clinical utility depending on clinical and genetic heterogeneity of a particular syndrome. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Genetic testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     MINCEP Epilepsy Reports. Published by the Minnesota Comprehensive Epilepsy Program, Minneapolis, Minnesota. 2000; Vol IX, Number 1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/2\">",
"      Martin ET, Kerin T, Christakis DA, et al. Redefining outcome of first seizures by acute illness. Pediatrics 2010; 126:e1477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/3\">",
"      Cai S, Hamiwka LD, Wirrell EC. Peri-ictal headache in children: prevalence and character. Pediatr Neurol 2008; 39:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/4\">",
"      Fogarasi A, Tuxhorn I, Hegyi M, Janszky J. Predictive clinical factors for the differential diagnosis of childhood extratemporal seizures. Epilepsia 2005; 46:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/5\">",
"      Fogarasi A, Janszky J, Tuxhorn I. Peri-ictal lateralizing signs in children: blinded multiobserver study of 100 children &lt; or =12 years. Neurology 2006; 66:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/6\">",
"      Walczak TS, Bogolioubov A. Weeping during psychogenic nonepileptic seizures. Epilepsia 1996; 37:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/7\">",
"      Fl&uuml;gell, D, Bauer, J, K&auml;seborn, U, et al. Closed Eyes during a seizure indicate psychogenic etiology: A study with suggestive seizure provocation. J Epilepsy 1996; 9:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/8\">",
"      Korff CM, Nordli DR Jr. Paroxysmal events in infants: persistent eye closure makes seizures unlikely. Pediatrics 2005; 116:e485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/9\">",
"      Fastenau PS, Johnson CS, Perkins SM, et al. Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits. Neurology 2009; 73:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/10\">",
"      Caplan R, Siddarth P, Vona P, et al. Language in pediatric epilepsy. Epilepsia 2009; 50:2397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/11\">",
"      Bhise VV, Burack GD, Mandelbaum DE. Baseline cognition, behavior, and motor skills in children with new-onset, idiopathic epilepsy. Dev Med Child Neurol 2010; 52:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/12\">",
"      Kerr MP, Mensah S, Besag F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011; 52:2133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/13\">",
"      Rai D, Kerr MP, McManus S, et al. Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia 2012; 53:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/14\">",
"      Sherman EM, Brooks BL, Fay-McClymont TB, MacAllister WS. Detecting epilepsy-related cognitive problems in clinically referred children with epilepsy: is the WISC-IV a useful tool? Epilepsia 2012; 53:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/15\">",
"      Modi AC, King AS, Monahan SR, et al. Even a single seizure negatively impacts pediatric health-related quality of life. Epilepsia 2009; 50:2110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/16\">",
"      Benavente-Aguilar I, Morales-Bl&aacute;nquez C, Rubio EA, Rey JM. Quality of life of adolescents suffering from epilepsy living in the community. J Paediatr Child Health 2004; 40:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/17\">",
"      Ronen GM, Streiner DL, Rosenbaum P, Canadian Pediatric Epilepsy Network. Health-related quality of life in children with epilepsy: development and validation of self-report and parent proxy measures. Epilepsia 2003; 44:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/18\">",
"      Hamiwka L, Singh N, Niosi J, Wirrell E. Perceived health in children presenting with a \"first seizure\". Epilepsy Behav 2008; 13:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/19\">",
"      MacCormick JM, McAlister H, Crawford J, et al. Misdiagnosis of long QT syndrome as epilepsy at first presentation. Ann Emerg Med 2009; 54:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/20\">",
"      Pavone L, Curatolo P, Rizzo R, et al. Epidermal nevus syndrome: a neurologic variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy. Neurology 1991; 41:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/21\">",
"      Gordon N. Hypomelanosis of Ito (incontinentia pigmenti achromians). Dev Med Child Neurol 1994; 36:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/22\">",
"      Gilbert DL, DeRoos S, Bare MA. Does sleep or sleep deprivation increase epileptiform discharges in pediatric electroencephalograms? Pediatrics 2004; 114:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/23\">",
"      DeRoos ST, Chillag KL, Keeler M, Gilbert DL. Effects of sleep deprivation on the pediatric electroencephalogram. Pediatrics 2009; 123:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/24\">",
"      Veldhuizen R, Binnie CD, Beintema DJ. The effect of sleep deprivation on the EEG in epilepsy. Electroencephalogr Clin Neurophysiol 1983; 55:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/25\">",
"      Wassmer E, Quinn E, Seri S, Whitehouse W. The acceptability of sleep-deprived electroencephalograms. Seizure 1999; 8:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/26\">",
"      Sadleir LG, Scheffer IE. Optimizing electroencephalographic studies for epilepsy diagnosis in children with new-onset seizures. Arch Neurol 2010; 67:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/27\">",
"      Liamsuwan S, Grattan-Smith P, Fagan E, et al. The value of partial sleep deprivation as a routine measure in pediatric electroencephalography. J Child Neurol 2000; 15:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/28\">",
"      King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998; 352:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/29\">",
"      Carpay JA, de Weerd AW, Schimsheimer RJ, et al. The diagnostic yield of a second EEG after partial sleep deprivation: a prospective study in children with newly diagnosed seizures. Epilepsia 1997; 38:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/30\">",
"      Salinsky M, Kanter R, Dasheiff RM. Effectiveness of multiple EEGs in supporting the diagnosis of epilepsy: an operational curve. Epilepsia 1987; 28:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/31\">",
"      Camfield P, Gordon K, Camfield C, et al. EEG results are rarely the same if repeated within six months in childhood epilepsy. Can J Neurol Sci 1995; 22:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/32\">",
"      Betting LE, Mory SB, Lopes-Cendes I, et al. EEG features in idiopathic generalized epilepsy: clues to diagnosis. Epilepsia 2006; 47:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/33\">",
"      Okubo Y, Matsuura M, Asai T, et al. Epileptiform EEG discharges in healthy children: prevalence, emotional and behavioral correlates, and genetic influences. Epilepsia 1994; 35:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/34\">",
"      Cavazzuti GB, Cappella L, Nalin A. Longitudinal study of epileptiform EEG patterns in normal children. Epilepsia 1980; 21:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/35\">",
"      Borusiak P, Zilbauer M, Jenke AC. Prevalence of epileptiform discharges in healthy children--new data from a prospective study using digital EEG. Epilepsia 2010; 51:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/36\">",
"      Arthur TM, deGrauw TJ, Johnson CS, et al. Seizure recurrence risk following a first seizure in neurologically normal children. Epilepsia 2008; 49:1950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/37\">",
"      Berg AT, Mathern GW, Bronen RA, et al. Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy. Brain 2009; 132:2785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/38\">",
"      Hsieh DT, Chang T, Tsuchida TN, et al. New-onset afebrile seizures in infants: role of neuroimaging. Neurology 2010; 74:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/39\">",
"      Gaillard WD, Chiron C, Cross JH, et al. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia 2009; 50:2147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/40\">",
"      Spooner CG, Berkovic SF, Mitchell LA, et al. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 2006; 67:2147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/41\">",
"      Harden CL, Huff JS, Schwartz TH, et al. Reassessment: neuroimaging in the emergency patient presenting with seizure (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2007; 69:1772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/42\">",
"      Parikh S, Cohen BH, Gupta A, et al. Metabolic testing in the pediatric epilepsy unit. Pediatr Neurol 2008; 38:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/43\">",
"      Musumeci SA, Hagerman RJ, Ferri R, et al. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 1999; 40:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/44\">",
"      Singh R, Sutherland GR, Manson J. Partial seizures with focal epileptogenic electroencephalographic patterns in three related female patients with fragile-X syndrome. J Child Neurol 1999; 14:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/45\">",
"      Valente KD, Koiffmann CP, Fridman C, et al. Epilepsy in patients with angelman syndrome caused by deletion of the chromosome 15q11-13. Arch Neurol 2006; 63:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/46\">",
"      De Vivo DC, Trifiletti RR, Jacobson RI, et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/47\">",
"      Akman CI, Engelstad K, Hinton VJ, et al. Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency. Ann Neurol 2010; 67:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/48\">",
"      Yang H, Wang D, Engelstad K, et al. Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol 2011; 70:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/49\">",
"      Mullen SA, Suls A, De Jonghe P, et al. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 2010; 75:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/50\">",
"      Striano P, Weber YG, Toliat MR, et al. GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology 2012; 78:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/4/14409/abstract/51\">",
"      Ottman R, Hirose S, Jain S, et al. Genetic testing in the epilepsies--report of the ILAE Genetics Commission. Epilepsia 2010; 51:655.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6218 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.1.191.153-8DAC4F1F78-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14409=[""].join("\n");
var outline_f14_4_14409=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Setting in which episodes occur",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Behavior immediately prior to the event",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Physical description",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Behavior during the event",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Behavior after the event",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Neuropsychological and social assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other elements of the history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ELECTROENCEPHALOGRAM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Sleep EEG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Timing of the EEG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Obtaining repeat EEGs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Use of the EEG to determine the type of epilepsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Abnormal EEGs in healthy children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      NEUROIMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      LABORATORY TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Who should be tested?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Laboratory screening in undiagnosed epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      GENETIC TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34889?source=related_link\">",
"      Clinical features and diagnosis of fragile X syndrome in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32425?source=related_link\">",
"      Electroencephalography (EEG) in the diagnosis of seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=related_link\">",
"      Febrile seizures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=related_link\">",
"      Genetic counseling and testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26793?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/8/5257?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/49/13082?source=related_link\">",
"      Neuroimaging in the evaluation of seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29175?source=related_link\">",
"      Nonepileptic paroxysmal disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/0/18434?source=related_link\">",
"      Patient information: EEG (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/26/419?source=related_link\">",
"      Patient information: Seizures in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/30/15850?source=related_link\">",
"      The ketogenic diet",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_4_14410="Atrophie blanche";
var content_f14_4_14410=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F54537%7EDERM%2F56185%7EDERM%2F87627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F54537%7EDERM%2F56185%7EDERM%2F87627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atrophie blanche",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 210px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Depressed, atrophic, purpuric, and scarred areas characteristic of atrophie blanche.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Magro, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Chronic stasis dermatitis with multiple white, stellate scarring areas (atrophie blanche)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Atrophie blanche",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Atrophie blanche in a patient with lipodermatosclerosis: characteristic ivory-white, stellate fibrotic scars.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14410=[""].join("\n");
var outline_f14_4_14410=null;
var title_f14_4_14411="EHRA score of AF related symptoms";
var content_f14_4_14411=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F85688&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F85688&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    EHRA score of AF related symptoms",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        EHRA class",
"       </td>",
"       <td class=\"subtitle1\">",
"        Explanation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        EHRA I",
"       </td>",
"       <td>",
"        No symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        EHRA II",
"       </td>",
"       <td>",
"        Mild symptoms; normal daily activity not affected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        EHRA III",
"       </td>",
"       <td>",
"        Severe symptoms; normal daily activity affected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        EHRA IV",
"       </td>",
"       <td>",
"        Disabling symptoms; normal daily activity discontinued",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AF: atrial fibrillation; EHRA: European Heart Rhythm Association.",
"    </div>",
"    <div class=\"reference\">",
"     From: Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31:2369. By permission of the European Society of Cardiology. Copyright &copy; 2012 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14411=[""].join("\n");
var outline_f14_4_14411=null;
var title_f14_4_14412="Diagnostic criteria SUNCT SUNA";
var content_f14_4_14412=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F74387&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F74387&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for SUNCT and SUNA",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Diagnostic criteria for SUNCT (short lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       A. At least 20 attacks fulfilling criteria B-E",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       B. Attacks of unilateral, orbital, supraorbital, or temporal stabbing or pulsating pain last 5 to 240 seconds",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       C. Pain is accompanied by ipsilateral conjunctival injection and lacrimation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       D. Attacks occur with a frequency from 3 to 200 per day",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       E. Not attributed to another disorder",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Diagnostic criteria for SUNA (short lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       A. At least 20 attacks fulfilling criteria B-E",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       B. Attacks of unilateral orbital, supraorbital or temporal stabbing pain lasting from 2 seconds to 10 minutes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       C. Pain is accompanied by one of:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       1. Conjunctival injection and/or tearing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       2. Nasal congestion and/or rhinorrhea",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       3. Eyelid edema",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       D. Attacks occur with a frequency of &ge;1 per day for more than half the time",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       E. Not attributed to another disorder",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Episodic SUNA:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       SUNA attacks occurring for seven days to one year with pain free intervals longer than one month",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Chronic SUNA:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       At least two attack periods last seven days to one year separated by remission periods of less than one month (untreated)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted by permission of Sage: Headache classification subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9. Copyright &copy; 2004 Sage Publications.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14412=[""].join("\n");
var outline_f14_4_14412=null;
var title_f14_4_14413="Wilms tumor staging";
var content_f14_4_14413=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Staging systems for renal tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        NWTSG (before chemotherapy)",
"       </td>",
"       <td class=\"subtitle1\">",
"        SIOP (after chemotherapy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        I",
"       </td>",
"       <td>",
"        Tumor is limited to the kidney and completely excised",
"       </td>",
"       <td>",
"        Tumor is limited to kidney or surrounded with fibrous pseudocapsule if outside of the normal ontours of the kidney, the renal capsule or pseudocapsule may be infiltrated with the tumor, but it does not reach the outer surface, and is completely resected (resection margins \"clear\")",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The tumor was not ruptured before or during removal",
"       </td>",
"       <td>",
"        The tumor may be protruding into the pelvic system and \"dipping\" into the ureter (but it is not infiltrating their walls)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The vessels of the renal sinus are not involved beyond 2 mm",
"       </td>",
"       <td>",
"        The vessels of the renal sinus are not involved",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        There is no residual tumor apparent beyond the margins of excision",
"       </td>",
"       <td>",
"        Intrarenal vessel involvement may be present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        II",
"       </td>",
"       <td>",
"        Tumor extends beyond the kidney but is completely excised",
"       </td>",
"       <td>",
"        The tumor extends beyond kidney or penetrates through the renal capsule and/or fibrous pseudocapsule into perirenal fat but is completely resected (resection margins \"clear\")",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No residual tumor is apparent at or beyond the margins of excision",
"       </td>",
"       <td>",
"        The tumor infiltrates the renal sinus and/or invades blood and lymphatic vessels outside the renal parenchyma but is completely resected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tumor thrombus in vessels outside the kidney is stage II if the thrombus is removed en bloc with the tumor",
"       </td>",
"       <td>",
"        The tumor infiltrates adjacent organs or vena cava but is completely resected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Although tumor biopsy or local spillage confined to the flank were considered stage II by NWTSG in the past, such events will be considered stage III in upcoming COG studies.",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"8\">",
"        <p>",
"         III",
"        </p>",
"        <p>",
"         Residual tumor confined to the abdomen",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymph nodes in the renal hilum, the periaortic chains, or beyond are found to contain tumor",
"       </td>",
"       <td>",
"        Incomplete excision of the tumor, which extends beyond resection margins (gross or microscopical tumor remains postoperatively)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diffuse peritoneal contamination by the tumor",
"       </td>",
"       <td>",
"        Any abdominal lymph nodes are involved",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Implants are found on the peritoneal surfaces",
"       </td>",
"       <td>",
"        Tumor rupture before or intraoperatively (irrespective of other criteria for staging)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tumor extends beyond the surgical margins either microscopically or grossly",
"       </td>",
"       <td>",
"        The tumor has penetrated through the peritoneal surface",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tumor is not completely resectable because of local infiltration into vital structures",
"       </td>",
"       <td>",
"        Tumor thrombi present at resection margins of vessels or ureter, transsected or removed piecemeal by surgeon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        The tumor has been surgically biopsied (wedge biopsy) prior to preoperative chemotherapy or surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Regional lymph node involvement was considered stage II in the previous SIOP staging system.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        Presence of hematogenous metastases or metastases to distant lymph nodes",
"       </td>",
"       <td>",
"        Hematogenous metastases (lung, liver, bone, brain, etc.) or lymph node metastases outside the abdomino-pelvic region",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        V",
"       </td>",
"       <td>",
"        Bilateral renal involvement at the time of initial diagnosis",
"       </td>",
"       <td>",
"        Bilateral renal tumors at diagnosis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     COG: Children's Oncology Group; NWTSG: National Wilms Tumor Study Group; SIOP: International Society of Pediatric Oncology.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Metzger ML, Dome JS. Current therapy for Wilms' tumor. Oncologist 2005; 10:815. Copyright &copy;2005 AlphaMed Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14413=[""].join("\n");
var outline_f14_4_14413=null;
var title_f14_4_14414="Accelerated t PA in acute MI";
var content_f14_4_14414=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65005&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65005&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 513px\">",
"   <div class=\"ttl\">",
"    Benefit of accelerated t-PA in acute myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 493px; height: 243px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The overall one-year mortality for patients treated with different thrombolytic strategies in the GUSTO-1 trial. The mortality rate was lower in patients treated with accelerated t-PA compared to those receiving streptokinase and either intravenous (IV) or subcutaneous (SQ) heparin (p = 0.003) or t-PA and streptokinase in combination (p = 0.05).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Califf RM, White HD, Van de Werk F, et al for the GUSTO-1 Investigators, Circulation 1996; 94:1233.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14414=[""].join("\n");
var outline_f14_4_14414=null;
var title_f14_4_14415="Oblique med meniscus tear";
var content_f14_4_14415=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F65888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F65888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oblique tear of the medial meniscus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 316px; height: 389px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This sagittal short tau inversion recovery (STIR) magnetic resonance image of the knee demonstrates bright signal (arrow) extending to the inferior surface of the medial meniscus that is consistent with an oblique tear.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahla Modarresi, MD and Cecilia M Jude, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_4_14415=[""].join("\n");
var outline_f14_4_14415=null;
